ZEALAND PHARMA A/S (22Z.DE) Stock Cash Flow
Europe - FRA:22Z - DK0060257814 - Common Stock
60.34 EUR
+60.34 (+Infinity%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 6.68B | -1.08B | -703.74M | -1.20B | -1.02B | |||
| Depreciation Amortization | 24.64M | 25.85M | 25.09M | 117.96M | 40.25M | |||
| Change In Working Capital | 33.18M | 228.51M | 76.04M | -9.51M | -211.25M | |||
| Interest Paid | 18.20M | 24.03M | 25.25M | 34.12M | 3.30M | |||
| Taxes Paid | -5.67M | -11.15M | -11.30M | -9.28M | 41.63M | |||
| Other non cash items | 803.98M | -106.35M | 176.95M | 151.37M | -22.82M | |||
| OPERATING CASH FLOW | 7.54B | -930.82M | -425.67M | -942.31M | -1.21B | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -19.02M | -13.15M | -23.75M | -11.71M | -22.13M | |||
| Other Investing Activity | -6.92B | -7.32B | -1.07B | 292.97M | 4.01M | |||
| INVESTING CASH FLOW | -6.94B | -7.33B | -1.09B | 281.26M | -18.12M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -17.53M | 353.43M | -543.43M | -449.81M | 633.19M | |||
| Stock Issued/Repurchased | -567.39M | 8.17B | 1.52B | 1.08B | 746.46M | |||
| Other Financing Activity | -2.46M | -236.58M | -71.91M | -47.35M | -46.90M | |||
| FINANCING CASH FLOW | -587.38M | 8.29B | 907.01M | 587.50M | 1.33B | |||
| Exchange Rate Effect | -168.67M | 6.23M | -7.24M | 13.68M | 66.22M | |||
| CHANGE IN CASH | -157.00M | 30.99M | -619.92M | -59.87M | 168.88M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 7.54B | -930.82M | -425.67M | -942.31M | -1.21B | |||
| Capital Expenditure | -19.02M | -13.15M | -23.75M | -11.71M | -22.13M | |||
| FREE CASH FLOW | 7.52B | -943.96M | -449.42M | -954.02M | -1.23B | |||
All data in DKK